nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—SCN10A—skin cancer	0.875	1	CbGaD
Cinchocaine—SCN10A—nerve—skin cancer	0.00412	0.072	CbGeAlD
Cinchocaine—CALM2—ear—skin cancer	0.00404	0.0705	CbGeAlD
Cinchocaine—CALM1—ear—skin cancer	0.00402	0.0702	CbGeAlD
Cinchocaine—CALM2—nerve—skin cancer	0.00254	0.0444	CbGeAlD
Cinchocaine—CALM1—nerve—skin cancer	0.00253	0.0442	CbGeAlD
Cinchocaine—CALM2—endothelium—skin cancer	0.00216	0.0378	CbGeAlD
Cinchocaine—CALM1—endothelium—skin cancer	0.00215	0.0376	CbGeAlD
Cinchocaine—CALM2—hair follicle—skin cancer	0.00213	0.0372	CbGeAlD
Cinchocaine—Proparacaine—SCN10A—skin cancer	0.0021	0.314	CrCbGaD
Cinchocaine—CALM2—blood vessel—skin cancer	0.002	0.0349	CbGeAlD
Cinchocaine—CALM1—blood vessel—skin cancer	0.00199	0.0347	CbGeAlD
Cinchocaine—Oxybuprocaine—SCN10A—skin cancer	0.00192	0.287	CrCbGaD
Cinchocaine—CALM3—nipple—skin cancer	0.00184	0.0321	CbGeAlD
Cinchocaine—Chloroprocaine—SCN10A—skin cancer	0.00178	0.267	CrCbGaD
Cinchocaine—CALM2—nipple—skin cancer	0.00144	0.0252	CbGeAlD
Cinchocaine—CALM1—nipple—skin cancer	0.00144	0.0251	CbGeAlD
Cinchocaine—CALM2—neck—skin cancer	0.00143	0.0249	CbGeAlD
Cinchocaine—CALM1—neck—skin cancer	0.00142	0.0248	CbGeAlD
Cinchocaine—SCN10A—lymphoid tissue—skin cancer	0.00121	0.0212	CbGeAlD
Cinchocaine—BCHE—nipple—skin cancer	0.0012	0.021	CbGeAlD
Cinchocaine—CALM3—mammalian vulva—skin cancer	0.00107	0.0187	CbGeAlD
Cinchocaine—CALM2—connective tissue—skin cancer	0.00102	0.0179	CbGeAlD
Cinchocaine—CALM1—connective tissue—skin cancer	0.00102	0.0178	CbGeAlD
Cinchocaine—SCN10A—head—skin cancer	0.000978	0.0171	CbGeAlD
Cinchocaine—CALM2—epithelium—skin cancer	0.000972	0.017	CbGeAlD
Cinchocaine—CALM1—epithelium—skin cancer	0.000967	0.0169	CbGeAlD
Cinchocaine—CALM2—skin of body—skin cancer	0.000924	0.0161	CbGeAlD
Cinchocaine—CALM1—skin of body—skin cancer	0.00092	0.0161	CbGeAlD
Cinchocaine—SCN5A—head—skin cancer	0.000888	0.0155	CbGeAlD
Cinchocaine—Procainamide—SCN10A—skin cancer	0.00088	0.132	CrCbGaD
Cinchocaine—CALM2—mammalian vulva—skin cancer	0.000843	0.0147	CbGeAlD
Cinchocaine—CALM1—mammalian vulva—skin cancer	0.000839	0.0147	CbGeAlD
Cinchocaine—BCHE—skin of body—skin cancer	0.000771	0.0135	CbGeAlD
Cinchocaine—CALM2—lymphoid tissue—skin cancer	0.000748	0.0131	CbGeAlD
Cinchocaine—CALM1—lymphoid tissue—skin cancer	0.000745	0.013	CbGeAlD
Cinchocaine—CALM2—female reproductive system—skin cancer	0.000722	0.0126	CbGeAlD
Cinchocaine—CALM1—female reproductive system—skin cancer	0.000719	0.0126	CbGeAlD
Cinchocaine—BCHE—mammalian vulva—skin cancer	0.000703	0.0123	CbGeAlD
Cinchocaine—SCN10A—lymph node—skin cancer	0.000685	0.012	CbGeAlD
Cinchocaine—CALM2—head—skin cancer	0.000603	0.0105	CbGeAlD
Cinchocaine—BCHE—female reproductive system—skin cancer	0.000602	0.0105	CbGeAlD
Cinchocaine—CALM1—head—skin cancer	0.0006	0.0105	CbGeAlD
Cinchocaine—CALM3—lymph node—skin cancer	0.000538	0.00939	CbGeAlD
Cinchocaine—BCHE—head—skin cancer	0.000503	0.00878	CbGeAlD
Cinchocaine—CALM2—lymph node—skin cancer	0.000422	0.00738	CbGeAlD
Cinchocaine—CALM1—lymph node—skin cancer	0.00042	0.00734	CbGeAlD
Cinchocaine—BCHE—lymph node—skin cancer	0.000352	0.00615	CbGeAlD
Cinchocaine—CALM3—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	3.34e-05	0.000542	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 signaling—HRAS—skin cancer	3.34e-05	0.000541	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signaling of activated FGFR—IL6—skin cancer	3.34e-05	0.000541	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signaling of activated FGFR—IL6—skin cancer	3.34e-05	0.000541	CbGpPWpGaD
Cinchocaine—CALM3—Disease—ENO2—skin cancer	3.31e-05	0.000537	CbGpPWpGaD
Cinchocaine—CALM3—Disease—SHH—skin cancer	3.31e-05	0.000537	CbGpPWpGaD
Cinchocaine—CALM2—B Cell Activation—KRAS—skin cancer	3.31e-05	0.000537	CbGpPWpGaD
Cinchocaine—CALM1—B Cell Activation—KRAS—skin cancer	3.31e-05	0.000537	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—GLI2—skin cancer	3.3e-05	0.000535	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—GLI2—skin cancer	3.3e-05	0.000535	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signal transduction—HRAS—skin cancer	3.28e-05	0.000532	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signal transduction—HRAS—skin cancer	3.28e-05	0.000532	CbGpPWpGaD
Cinchocaine—CALM3—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	3.27e-05	0.000531	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by FGFR—HRAS—skin cancer	3.26e-05	0.000529	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by FGFR—HRAS—skin cancer	3.26e-05	0.000529	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MC1R—skin cancer	3.25e-05	0.000528	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by ERBB2—HRAS—skin cancer	3.25e-05	0.000526	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by ERBB2—HRAS—skin cancer	3.25e-05	0.000526	CbGpPWpGaD
Cinchocaine—CALM3—Downstream signal transduction—IL6—skin cancer	3.24e-05	0.000526	CbGpPWpGaD
Cinchocaine—CALM2—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	3.24e-05	0.000524	CbGpPWpGaD
Cinchocaine—CALM1—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	3.24e-05	0.000524	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 signaling—HRAS—skin cancer	3.23e-05	0.000524	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 signaling—HRAS—skin cancer	3.23e-05	0.000524	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by FGFR—IL6—skin cancer	3.23e-05	0.000523	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by ERBB2—IL6—skin cancer	3.21e-05	0.000521	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—GLI1—skin cancer	3.21e-05	0.00052	CbGpPWpGaD
Cinchocaine—CALM2—Disease—SHH—skin cancer	3.2e-05	0.000519	CbGpPWpGaD
Cinchocaine—CALM1—Disease—SHH—skin cancer	3.2e-05	0.000519	CbGpPWpGaD
Cinchocaine—CALM2—Disease—ENO2—skin cancer	3.2e-05	0.000519	CbGpPWpGaD
Cinchocaine—CALM1—Disease—ENO2—skin cancer	3.2e-05	0.000519	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 signaling—IL6—skin cancer	3.2e-05	0.000518	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—HRAS—skin cancer	3.17e-05	0.000514	CbGpPWpGaD
Cinchocaine—CALM2—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	3.17e-05	0.000513	CbGpPWpGaD
Cinchocaine—CALM1—NGF signalling via TRKA from the plasma membrane—KRAS—skin cancer	3.17e-05	0.000513	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MC1R—skin cancer	3.15e-05	0.00051	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MC1R—skin cancer	3.15e-05	0.00051	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 interactions—HRAS—skin cancer	3.14e-05	0.000509	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by FGFR in disease—HRAS—skin cancer	3.14e-05	0.000509	CbGpPWpGaD
Cinchocaine—CALM3—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	3.14e-05	0.000509	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signal transduction—IL6—skin cancer	3.14e-05	0.000509	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signal transduction—IL6—skin cancer	3.14e-05	0.000509	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by FGFR—IL6—skin cancer	3.12e-05	0.000506	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by FGFR—IL6—skin cancer	3.12e-05	0.000506	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR—HRAS—skin cancer	3.11e-05	0.000505	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by ERBB2—IL6—skin cancer	3.11e-05	0.000504	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by ERBB2—IL6—skin cancer	3.11e-05	0.000504	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—GLI1—skin cancer	3.1e-05	0.000503	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—GLI1—skin cancer	3.1e-05	0.000503	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 signaling—IL6—skin cancer	3.09e-05	0.000501	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 signaling—IL6—skin cancer	3.09e-05	0.000501	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR in Cancer—HRAS—skin cancer	3.09e-05	0.0005	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by PDGF—HRAS—skin cancer	3.07e-05	0.000498	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SUFU—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by FGFR in disease—HRAS—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 interactions—HRAS—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—CALM2—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—CALM1—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by FGFR in disease—HRAS—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 interactions—HRAS—skin cancer	3.04e-05	0.000493	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—IL6—skin cancer	3.03e-05	0.000492	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR—HRAS—skin cancer	3.01e-05	0.000488	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR—HRAS—skin cancer	3.01e-05	0.000488	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 interactions—IL6—skin cancer	3.01e-05	0.000488	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by FGFR in disease—IL6—skin cancer	3.01e-05	0.000488	CbGpPWpGaD
Cinchocaine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	3.01e-05	0.000488	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR in Cancer—HRAS—skin cancer	2.99e-05	0.000484	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR in Cancer—HRAS—skin cancer	2.99e-05	0.000484	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR—IL6—skin cancer	2.98e-05	0.000483	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by PDGF—HRAS—skin cancer	2.97e-05	0.000482	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by PDGF—HRAS—skin cancer	2.97e-05	0.000482	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by EGFR in Cancer—IL6—skin cancer	2.95e-05	0.000479	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SUFU—skin cancer	2.94e-05	0.000477	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SUFU—skin cancer	2.94e-05	0.000477	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by PDGF—IL6—skin cancer	2.94e-05	0.000477	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—NRAS—skin cancer	2.93e-05	0.000474	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—FOXO4—skin cancer	2.92e-05	0.000474	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 interactions—IL6—skin cancer	2.91e-05	0.000472	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by FGFR in disease—IL6—skin cancer	2.91e-05	0.000472	CbGpPWpGaD
Cinchocaine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.91e-05	0.000472	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 interactions—IL6—skin cancer	2.91e-05	0.000472	CbGpPWpGaD
Cinchocaine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	2.91e-05	0.000472	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by FGFR in disease—IL6—skin cancer	2.91e-05	0.000472	CbGpPWpGaD
Cinchocaine—CALM3—B Cell Activation—HRAS—skin cancer	2.91e-05	0.000471	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR—IL6—skin cancer	2.88e-05	0.000467	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR—IL6—skin cancer	2.88e-05	0.000467	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by EGFR in Cancer—IL6—skin cancer	2.86e-05	0.000463	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by EGFR in Cancer—IL6—skin cancer	2.86e-05	0.000463	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—HRAS—skin cancer	2.85e-05	0.000462	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by PDGF—IL6—skin cancer	2.85e-05	0.000461	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by PDGF—IL6—skin cancer	2.85e-05	0.000461	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—NRAS—skin cancer	2.83e-05	0.000459	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—NRAS—skin cancer	2.83e-05	0.000459	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—FOXO4—skin cancer	2.83e-05	0.000459	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—FOXO4—skin cancer	2.83e-05	0.000459	CbGpPWpGaD
Cinchocaine—CALM2—B Cell Activation—HRAS—skin cancer	2.81e-05	0.000456	CbGpPWpGaD
Cinchocaine—CALM1—B Cell Activation—HRAS—skin cancer	2.81e-05	0.000456	CbGpPWpGaD
Cinchocaine—CALM3—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.78e-05	0.000451	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ENO2—skin cancer	2.77e-05	0.00045	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—HRAS—skin cancer	2.76e-05	0.000447	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—HRAS—skin cancer	2.76e-05	0.000447	CbGpPWpGaD
Cinchocaine—CALM3—Disease—FOXO4—skin cancer	2.7e-05	0.000438	CbGpPWpGaD
Cinchocaine—CALM1—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.69e-05	0.000436	CbGpPWpGaD
Cinchocaine—CALM2—NGF signalling via TRKA from the plasma membrane—HRAS—skin cancer	2.69e-05	0.000436	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ENO2—skin cancer	2.68e-05	0.000435	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ENO2—skin cancer	2.68e-05	0.000435	CbGpPWpGaD
Cinchocaine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.66e-05	0.000432	CbGpPWpGaD
Cinchocaine—CALM1—Disease—FOXO4—skin cancer	2.61e-05	0.000423	CbGpPWpGaD
Cinchocaine—CALM2—Disease—FOXO4—skin cancer	2.61e-05	0.000423	CbGpPWpGaD
Cinchocaine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.58e-05	0.000418	CbGpPWpGaD
Cinchocaine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—skin cancer	2.58e-05	0.000418	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—KRAS—skin cancer	2.52e-05	0.000408	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—ERCC2—skin cancer	2.5e-05	0.000406	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—KRAS—skin cancer	2.44e-05	0.000395	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—KRAS—skin cancer	2.44e-05	0.000395	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SHH—skin cancer	2.32e-05	0.000376	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—RASA1—skin cancer	2.3e-05	0.000374	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SHH—skin cancer	2.24e-05	0.000364	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SHH—skin cancer	2.24e-05	0.000364	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—RASA1—skin cancer	2.23e-05	0.000361	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—RASA1—skin cancer	2.23e-05	0.000361	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—SMO—skin cancer	2.2e-05	0.000356	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PTCH1—skin cancer	2.2e-05	0.000356	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—HRAS—skin cancer	2.18e-05	0.000354	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—HRAS—skin cancer	2.14e-05	0.000347	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PTGER4—skin cancer	2.14e-05	0.000347	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—SMO—skin cancer	2.13e-05	0.000345	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PTCH1—skin cancer	2.13e-05	0.000345	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—SMO—skin cancer	2.13e-05	0.000345	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PTCH1—skin cancer	2.13e-05	0.000345	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—HRAS—skin cancer	2.11e-05	0.000342	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—HRAS—skin cancer	2.11e-05	0.000342	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—HRAS—skin cancer	2.07e-05	0.000336	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—HRAS—skin cancer	2.07e-05	0.000336	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PTGER4—skin cancer	2.07e-05	0.000336	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PTGER4—skin cancer	2.07e-05	0.000336	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by NGF—IL6—skin cancer	2.05e-05	0.000332	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by NGF—IL6—skin cancer	1.98e-05	0.000321	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by NGF—IL6—skin cancer	1.98e-05	0.000321	CbGpPWpGaD
Cinchocaine—CALM3—Disease—ERCC2—skin cancer	1.92e-05	0.000312	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—FOXO4—skin cancer	1.89e-05	0.000306	CbGpPWpGaD
Cinchocaine—CALM2—Disease—ERCC2—skin cancer	1.86e-05	0.000302	CbGpPWpGaD
Cinchocaine—CALM1—Disease—ERCC2—skin cancer	1.86e-05	0.000302	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—NRAS—skin cancer	1.85e-05	0.000301	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—FOXO4—skin cancer	1.83e-05	0.000296	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—FOXO4—skin cancer	1.83e-05	0.000296	CbGpPWpGaD
Cinchocaine—CALM3—Disease—TERT—skin cancer	1.8e-05	0.000292	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—NRAS—skin cancer	1.79e-05	0.000291	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—NRAS—skin cancer	1.79e-05	0.000291	CbGpPWpGaD
Cinchocaine—CALM2—Disease—TERT—skin cancer	1.74e-05	0.000283	CbGpPWpGaD
Cinchocaine—CALM1—Disease—TERT—skin cancer	1.74e-05	0.000283	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—NRAS—skin cancer	1.67e-05	0.000271	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—NRAS—skin cancer	1.61e-05	0.000262	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—NRAS—skin cancer	1.61e-05	0.000262	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—ERCC2—skin cancer	1.61e-05	0.000261	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—NRAS—skin cancer	1.6e-05	0.00026	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—KRAS—skin cancer	1.6e-05	0.000259	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—ERCC2—skin cancer	1.56e-05	0.000253	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—ERCC2—skin cancer	1.56e-05	0.000253	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—NRAS—skin cancer	1.55e-05	0.000251	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—NRAS—skin cancer	1.55e-05	0.000251	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—KRAS—skin cancer	1.54e-05	0.00025	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—KRAS—skin cancer	1.54e-05	0.00025	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—PTGS2—skin cancer	1.5e-05	0.000243	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—KRAS—skin cancer	1.44e-05	0.000233	CbGpPWpGaD
Cinchocaine—CALM3—Disease—BRAF—skin cancer	1.43e-05	0.000231	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—TP53—skin cancer	1.42e-05	0.00023	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—KRAS—skin cancer	1.39e-05	0.000225	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—KRAS—skin cancer	1.39e-05	0.000225	CbGpPWpGaD
Cinchocaine—CALM2—Disease—BRAF—skin cancer	1.38e-05	0.000224	CbGpPWpGaD
Cinchocaine—CALM1—Disease—BRAF—skin cancer	1.38e-05	0.000224	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—KRAS—skin cancer	1.38e-05	0.000224	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—TP53—skin cancer	1.37e-05	0.000222	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—TP53—skin cancer	1.37e-05	0.000222	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—HRAS—skin cancer	1.36e-05	0.00022	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—KRAS—skin cancer	1.33e-05	0.000216	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—KRAS—skin cancer	1.33e-05	0.000216	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—HRAS—skin cancer	1.31e-05	0.000213	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—HRAS—skin cancer	1.31e-05	0.000213	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—TERT—skin cancer	1.26e-05	0.000205	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TERT—skin cancer	1.22e-05	0.000198	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TERT—skin cancer	1.22e-05	0.000198	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—HRAS—skin cancer	1.22e-05	0.000198	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—HRAS—skin cancer	1.18e-05	0.000191	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—HRAS—skin cancer	1.18e-05	0.000191	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—HRAS—skin cancer	1.17e-05	0.00019	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—IL6—skin cancer	1.17e-05	0.000189	CbGpPWpGaD
Cinchocaine—CALM3—Disease—PTGS2—skin cancer	1.15e-05	0.000187	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—HRAS—skin cancer	1.13e-05	0.000184	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—HRAS—skin cancer	1.13e-05	0.000184	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—IL6—skin cancer	1.13e-05	0.000183	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—IL6—skin cancer	1.13e-05	0.000183	CbGpPWpGaD
Cinchocaine—CALM1—Disease—PTGS2—skin cancer	1.12e-05	0.000181	CbGpPWpGaD
Cinchocaine—CALM2—Disease—PTGS2—skin cancer	1.12e-05	0.000181	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—NRAS—skin cancer	1.06e-05	0.000172	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—NRAS—skin cancer	1.03e-05	0.000167	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—NRAS—skin cancer	1.03e-05	0.000167	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—BRAF—skin cancer	1e-05	0.000162	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—NRAS—skin cancer	9.72e-06	0.000158	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—BRAF—skin cancer	9.67e-06	0.000157	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—BRAF—skin cancer	9.67e-06	0.000157	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—PTGS2—skin cancer	9.66e-06	0.000157	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—NRAS—skin cancer	9.4e-06	0.000152	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—NRAS—skin cancer	9.4e-06	0.000152	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—PTGS2—skin cancer	9.34e-06	0.000151	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—PTGS2—skin cancer	9.34e-06	0.000151	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—KRAS—skin cancer	9.16e-06	0.000148	CbGpPWpGaD
Cinchocaine—CALM3—Disease—NRAS—skin cancer	8.97e-06	0.000145	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—KRAS—skin cancer	8.86e-06	0.000144	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—KRAS—skin cancer	8.86e-06	0.000144	CbGpPWpGaD
Cinchocaine—CALM2—Disease—NRAS—skin cancer	8.68e-06	0.000141	CbGpPWpGaD
Cinchocaine—CALM1—Disease—NRAS—skin cancer	8.68e-06	0.000141	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—KRAS—skin cancer	8.37e-06	0.000136	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—KRAS—skin cancer	8.09e-06	0.000131	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—KRAS—skin cancer	8.09e-06	0.000131	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—HRAS—skin cancer	7.78e-06	0.000126	CbGpPWpGaD
Cinchocaine—CALM3—Disease—KRAS—skin cancer	7.72e-06	0.000125	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—HRAS—skin cancer	7.53e-06	0.000122	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—HRAS—skin cancer	7.53e-06	0.000122	CbGpPWpGaD
Cinchocaine—CALM2—Disease—KRAS—skin cancer	7.47e-06	0.000121	CbGpPWpGaD
Cinchocaine—CALM1—Disease—KRAS—skin cancer	7.47e-06	0.000121	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—IL6—skin cancer	7.45e-06	0.000121	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—IL6—skin cancer	7.21e-06	0.000117	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—IL6—skin cancer	7.21e-06	0.000117	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—HRAS—skin cancer	7.11e-06	0.000115	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—HRAS—skin cancer	6.88e-06	0.000112	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—HRAS—skin cancer	6.88e-06	0.000112	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL6—skin cancer	6.81e-06	0.00011	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL6—skin cancer	6.58e-06	0.000107	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL6—skin cancer	6.58e-06	0.000107	CbGpPWpGaD
Cinchocaine—CALM3—Disease—HRAS—skin cancer	6.57e-06	0.000106	CbGpPWpGaD
Cinchocaine—CALM2—Disease—HRAS—skin cancer	6.35e-06	0.000103	CbGpPWpGaD
Cinchocaine—CALM1—Disease—HRAS—skin cancer	6.35e-06	0.000103	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—NRAS—skin cancer	6.28e-06	0.000102	CbGpPWpGaD
Cinchocaine—CALM3—Disease—IL6—skin cancer	6.28e-06	0.000102	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—NRAS—skin cancer	6.08e-06	9.86e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—NRAS—skin cancer	6.08e-06	9.86e-05	CbGpPWpGaD
Cinchocaine—CALM1—Disease—IL6—skin cancer	6.08e-06	9.85e-05	CbGpPWpGaD
Cinchocaine—CALM2—Disease—IL6—skin cancer	6.08e-06	9.85e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—KRAS—skin cancer	5.41e-06	8.77e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—KRAS—skin cancer	5.23e-06	8.48e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—KRAS—skin cancer	5.23e-06	8.48e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—TP53—skin cancer	4.81e-06	7.79e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—TP53—skin cancer	4.65e-06	7.54e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—TP53—skin cancer	4.65e-06	7.54e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HRAS—skin cancer	4.6e-06	7.45e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HRAS—skin cancer	4.45e-06	7.21e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HRAS—skin cancer	4.45e-06	7.21e-05	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—IL6—skin cancer	4.4e-06	7.13e-05	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—IL6—skin cancer	4.26e-06	6.9e-05	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—IL6—skin cancer	4.26e-06	6.9e-05	CbGpPWpGaD
